These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 29441844)
1. Adjunctive therapy with V-5 Immunitor (V5) for the treatment of tuberculosis patients: a meta-analysis. Feng M; Ding Q; Zhong C; Li J; Wang Q; Yuan Z; Dong Y Pharmazie; 2016 Sep; 71(9):499-503. PubMed ID: 29441844 [TBL] [Abstract][Full Text] [Related]
2. Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis. Yang XY; Chen QF; Li YP; Wu SM PLoS One; 2011; 6(9):e23826. PubMed ID: 21909406 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant Efficacy of Nutrition Support During Pulmonary Tuberculosis Treating Course: Systematic Review and Meta-analysis. Si ZL; Kang LL; Shen XB; Zhou YZ Chin Med J (Engl); 2015 Dec; 128(23):3219-30. PubMed ID: 26612299 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: a meta-analysis of randomized controlled trials. Zhang J; Chen C; Yang J Chin Med J (Engl); 2019 Dec; 132(24):2950-2959. PubMed ID: 31833904 [TBL] [Abstract][Full Text] [Related]
6. Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C. Batdelger D; Dandii D; Jirathitikal V; Bourinbaiar AS Vaccine; 2008 May; 26(22):2733-7. PubMed ID: 18455842 [TBL] [Abstract][Full Text] [Related]
8. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Sharma SK; Sharma A; Kadhiravan T; Tharyan P Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581 [TBL] [Abstract][Full Text] [Related]
9. Moxifloxacin plus standard first-line therapy in the treatment of pulmonary tuberculosis: A meta-analysis. Chen Z; Liang JQ; Wang JH; Feng SS; Zhang GY Tuberculosis (Edinb); 2015 Jul; 95(4):490-6. PubMed ID: 25964137 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review. Gao XF; Yang ZW; Li J Int J Infect Dis; 2011 Sep; 15(9):e594-600. PubMed ID: 21715206 [TBL] [Abstract][Full Text] [Related]
11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis. Zhang R; Xi X; Wang C; Pan Y; Ge C; Zhang L; Zhang S; Liu H PLoS One; 2018; 13(7):e0201025. PubMed ID: 30024982 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis. Huang CY; Hsieh WY Hum Vaccin Immunother; 2017 Sep; 13(9):1960-1971. PubMed ID: 28604170 [TBL] [Abstract][Full Text] [Related]
14. Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis. Yang XY; Chen QF; Cui XH; Yu Y; Li YP J Infect; 2010 May; 60(5):320-30. PubMed ID: 20156481 [TBL] [Abstract][Full Text] [Related]
15. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors. Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750 [TBL] [Abstract][Full Text] [Related]
16. The effect of micro-nutrients on malnutrition, immunity and therapeutic effect in patients with pulmonary tuberculosis: A systematic review and meta-analysis of randomised controlled trials. Haiqing Cai ; Chen L; Yin C; Liao Y; Meng X; Lu C; Tang S; Li X; Wang X Tuberculosis (Edinb); 2020 Dec; 125():101994. PubMed ID: 33049436 [TBL] [Abstract][Full Text] [Related]
17. Traditional Chinese medicine combined with western medicine for the treatment of secondary pulmonary tuberculosis: A PRISMA-compliant meta-analysis. Li X; Li X; Liu Q; Sun N; Zhang B; Shi C; Zhang R Medicine (Baltimore); 2020 Apr; 99(16):e19567. PubMed ID: 32311924 [TBL] [Abstract][Full Text] [Related]
18. The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis. Hayford FEA; Dolman RC; Blaauw R; Nienaber A; Smuts CM; Malan L; Ricci C Respir Res; 2020 Aug; 21(1):223. PubMed ID: 32847532 [TBL] [Abstract][Full Text] [Related]
19. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
20. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB. Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]